Stay updated on Pembrolizumab with BCG post-ablation in UUTTCC Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab with BCG post-ablation in UUTTCC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab with BCG post-ablation in UUTTCC Clinical Trial page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    12 days ago
    Change Detected
    Summary
    The page now lists a Locations section with Michigan as a location, and the HHS Vulnerability Disclosure and Michigan Locations entries have been removed. The page revision is updated to v3.3.3.
    Difference
    0.2%
    Check dated 2025-12-23T17:30:58.000Z thumbnail image
  3. Check
    20 days ago
    No Change Detected
  4. Check
    27 days ago
    No Change Detected
  5. Check
    41 days ago
    Change Detected
    Summary
    Editorial updates to the Publications section add a note that publications are automatically filled from PubMed and update the page revision label to v3.3.2, replacing the previous PubMed wording and the earlier revision label. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-24T21:23:04.000Z thumbnail image
  6. Check
    48 days ago
    Change Detected
    Summary
    Removed the general operating status notice about government funding and NIH Clinical Center operations. The trial details, eligibility criteria, and contact information remain unchanged.
    Difference
    0.4%
    Check dated 2025-11-17T19:14:33.000Z thumbnail image
  7. Check
    63 days ago
    Change Detected
    Summary
    The new screenshot shows only minor formatting and wording changes with no modifications to the study content or user-facing functions. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-03T13:44:43.000Z thumbnail image
  8. Check
    91 days ago
    Change Detected
    Summary
    - Added a prominent notice about potential data and processing delays due to funding lapse and updated operating status guidance, and a new version tag v3.2.0. - Removed the previous version tag v3.1.0.
    Difference
    3%
    Check dated 2025-10-06T01:57:23.000Z thumbnail image
  9. Check
    98 days ago
    Change Detected
    Summary
    Updated revision to v3.1.0 with new contact details (phone numbers and email) and removal of the previous revision tag (v3.0.2).
    Difference
    0.1%
    Check dated 2025-09-28T23:23:09.000Z thumbnail image

Stay in the know with updates to Pembrolizumab with BCG post-ablation in UUTTCC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab with BCG post-ablation in UUTTCC Clinical Trial page.